Breast cancer Proteogenomics
21 – 40 of 44
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immune infiltrate in the primary tumor predicts effect of adjuvant radiotherapy in breast cancer : Results from the randomized SweBCG91RT trial
(
- Contribution to journal › Article
- 2020
-
Mark
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery : a long-term follow-up of the SweBCG91-RT randomised trial
(
- Contribution to journal › Article
-
Mark
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
(
- Contribution to journal › Article
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions - A feasibility study
(
- Contribution to journal › Article
-
Mark
Comprehensive transcriptomic profiling identifies breast cancer patients who may be spared adjuvant systemic therapy
(
- Contribution to journal › Article
- 2019
-
Mark
A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Inhibition of histone demethylases LSD1 and UTX regulates ERα signaling in breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
High-throughput molecular techniques and personalized treatment for primary breast cancer
2018)(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups
(
- Contribution to journal › Article
-
Mark
Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial
(
- Contribution to journal › Article
-
Mark
AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma
(
- Contribution to conference › Abstract
- 2016
-
Mark
Localization of Tamoxifen in Human Breast Tumor by MALDI Mass Spectrometry Imaging
(
- Contribution to journal › Article
-
Mark
Cancer associated proteins in blood plasma : Determining normal variation
(
- Contribution to journal › Article
- 2015
-
Mark
Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
(
- Contribution to journal › Article
-
Mark
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery
(
- Contribution to journal › Article
-
Mark
Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
(
- Contribution to journal › Article
-
Mark
Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.
(
- Contribution to journal › Article
- 2012
-
Mark
Reproducible Quantification of Cancer-Associated Proteins in Body Fluids Using Targeted Proteomics
(
- Contribution to journal › Article
- 2010
-
Mark
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.
(
- Contribution to journal › Article